Ziyan Pan

Hawkesbury Rd
Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Health inequity and the risk of MAFLD/MASLD.

Health inequity and the risk of MAFLD/MASLD.

Journal: Clinical nutrition ESPEN

Published: March 23, 2026

Reply to correspondence on "Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease".

Reply to correspondence on "Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease".

Journal: Clinical and molecular hepatology

Published: January 27, 2026

Epigenetic Aging Biomarkers in Lean MAFLD.

Epigenetic Aging Biomarkers in Lean MAFLD.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 07, 2026

Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis.

Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis.

Journal: Drug design, development and therapy

Published: December 22, 2025

A call for more efforts to incorporate liver in the metabolic health framework: Letter to the editor on "Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease".

A call for more efforts to incorporate liver in the metabolic health framework: Letter to the editor on "Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease".

Journal: Clinical and molecular hepatology

Published: December 16, 2025

Diagnostic criteria for fatty liver disease: lessons from other diseases.

Diagnostic criteria for fatty liver disease: lessons from other diseases.

Journal: Hepatology international

Published: December 15, 2025

Differential DNAm-GDF15 and mitochondrial profile in lean MAFLD.

Differential DNAm-GDF15 and mitochondrial profile in lean MAFLD.

Journal: Clinical and experimental medicine

Published: September 18, 2025

What is new in the 2025 APASL guidelines for metabolic dysfunction-associated fatty liver disease?

What is new in the 2025 APASL guidelines for metabolic dysfunction-associated fatty liver disease?

Journal: Hepatobiliary surgery and nutrition

Published: August 12, 2025

The Current and Future Burden of Metabolic Dysfunction-related Cancers in Arab Countries, 2022-2050.

The Current and Future Burden of Metabolic Dysfunction-related Cancers in Arab Countries, 2022-2050.

Journal: Oman medical journal

Published: August 08, 2025

The burden of metabolic diseases in the Arab region, 1990-2021.

The burden of metabolic diseases in the Arab region, 1990-2021.

Journal: Therapeutic advances in endocrinology and metabolism

Published: July 28, 2025

Lean MASH: A High-Risk Subtype With Significant Cardiometabolic Burden.

Lean MASH: A High-Risk Subtype With Significant Cardiometabolic Burden.

Journal: Journal of gastroenterology and hepatology

Published: July 01, 2025

Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990-2021.

Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990-2021.

Journal: Annals of hepatology

Published: June 03, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026